NEWARK, Del., May 26, 2020 /PRNewswire/ — Today, the National Institute for Innovation in Biopharmaceutical Manufacturing (NIIMBL) announces that they have received $8.9 million from the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST). This award will fund high-impact projects that will support the nation’s response to the COVID-19 pandemic. The funding is part of the first round of funding made available to NIST through the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
{iframe}https://www.prnewswire.com/news-releases/niimbl-is-awarded-8-9m-from-nist-for-high-impact-manufacturing-projects-to-respond-to-pandemic-301065555.html{/iframe}